SCHEMBL6948423

SCHEMBL6948423

N#Cc1c(N2CCc3ccccc3CC2)nc(C2CC2)[nH]c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
NPSR1 Q6W5P4 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CXCR2 P25025 3/20 0.42
KDM4E B2RXH2 4/20 0.40
HPGD P15428 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
GAA P10253 2/20 0.39
LMNA P02545 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HSD17B10 Q99714 2/20 0.39
HTT P42858 2/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
PARP1 P09874 1/20 0.38
PDE9A O76083 1/20 0.37
POLB P06746 2/20 0.37
GLA P06280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6949962 0.82 GAA (0.43) ALDH1A1NPSR1SMN1; SMN2KDM4EHPGD
SCHEMBL6948400 0.82 XDH (0.51) ALDH1A1NPSR1SMN1; SMN2KDM4EHPGD
SCHEMBL6951832 0.80 ALDH1A1 (0.45) ALDH1A1NPSR1SMN1; SMN2KDM4EHPGD
SCHEMBL6955411 0.80 RXFP1 (0.54) ALDH1A1NPSR1SMN1; SMN2CXCR2KDM4E
SCHEMBL6952723 0.80 PDE9A (0.44) ALDH1A1NPSR1SMN1; SMN2KDM4EHPGD
SCHEMBL6948386 0.78 ALDH1A1 (0.41) ALDH1A1NPSR1SMN1; SMN2KDM4EHPGD
SCHEMBL6945649 0.78 PDE9A (0.41) ALDH1A1NPSR1SMN1; SMN2KDM4EHPGD
SCHEMBL6945691 0.78 PDE9A (0.45) ALDH1A1NPSR1SMN1; SMN2KDM4EHPGD
SCHEMBL6953105 0.77 ALDH1A1 (0.42) ALDH1A1NPSR1SMN1; SMN2KDM4EHPGD
SCHEMBL6948390 0.77 ALDH1A1 (0.42) ALDH1A1NPSR1SMN1; SMN2KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed